Novel thromboresistant materials

Journal of Vascular Surgery

Volumn 45, Issue 6 SUPPL., 2007, Pages A104-A115

  Jordan, Sumanas W ^a   Chaikof, Elliot L ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALBUMIN; BIOMATERIAL; DIPYRIDAMOLE; HIRUDIN; MACROGOL; NITINOL; PHOSPHORYLCHOLINE; POLITEF; POLY(VINYLAMINE); POLYACRYLIC ACID; POLYETHERURETHAN; POLYETHERURETHANUREA; POLYETHYLENE; POLYGLACTIN; POLYMER; PYROLYTIC CARBON; SALICYLIC ACID; STAINLESS STEEL; THROMBIN INHIBITOR; THROMBOMODULIN; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; ARTIFICIAL HEART; ARTIFICIAL KIDNEY; ARTIFICIAL LIVER; ARTIFICIAL LUNG; BIOSENSOR; BLOOD VESSEL GRAFT; CHEMICAL STRUCTURE; EVALUATION; FIBRIN FORMATION; HUMAN; MATERIAL COATING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STRUCTURE ANALYSIS; SURFACE PROPERTY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS;

EID: 34249319466     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.02.048     Document Type: Article

References (188)

1. Pereira C.E., Albers M., Romiti M., Brochado-Neto F.C., and Braganaa Pereira C.A. Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. J Vasc Surg 44 (2006) 510-517
2. Klinkert P., Post P.N., Breslau P.J., and van Bocke J.H. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 27 (2004) 357-362
3. Albers M., Battistella V.M., Romiti M., Rodrigues A.A.E., and Pereira C.A.B. Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg 37 (2003) 1263-1269
4. Klinkert P., Schepers A., Burger D.H.C., van Bockel J.H., and Breslau P.J. Vein versus polytetrafluoroethylene in above-knee femoropoplitcal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg 37 (2003) 149-155
5. Burger D.H., Kappetein A.P., Van Bockel J.H., and Breslau P.J. A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting. J Vasc Surg 32 (2000) 278-283
6. Johnson W.C., and Lee K.K. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 32 (2000) 268-277
7. Johnson W.C., and Lee K.K. Comparative evaluation of externally supported Dacron and polytetrafluoroethylene prosthetic bypasses for femorofemoral and axillofemoral arterial reconstructions. J Vasc Surg 30 (1999) 1077-1083
8. Serruys P.W., Dejaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary-artery disease. N Engl J Med 331 (1994) 489-495
9. Sigwart U., Puel J., Mirkovitch V., Joffre F., and Kappenberger L. Intravascular stents to prevent occlusion and restenosis after trans-luminal angioplasty. N Engl J Med 316 (1987) 701-706
10. Kozak L.J., DeFrances C.J., and Hall M.J. National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data. Vital and health statistics (2006) 1-209
11. Cutlip D.E., Baim D.S., Ho K.K.L., Popma J.J., Lansky A.J., Cohen D.J., et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2001) 1967-1971
12. Andrade J.D., and Hlady V. Protein adsorption and materials biocompatibility-a tutorial review and suggested hypotheses. Adv Polym Sci 79 (1986) 1-63
13. Merrill E.W., and Salzman E.W. Polyethylene oxide as a biomaterial. ASAIO J 6 (1983) 1
14. Lee J.H., Lee H.B., and Andrade J.D. Blood compatibility of polyethylene oxide surfaces. Prog Polym Sci 20 (1995) 1043-1079
15. Lyman D.J., Klein K.G., Brash J.J., Fritzinger B.K., Andrade J.D., and Banoma F.S. Platelet interaction with protein coated surfaces. Thromb Diath Haemor Proc 42 (1970) 6
16. Kim S.W., Lee R.G., Oster H., Coleman D., Andrade J.D., Lentz D.J., et al. Platelet adhesion to polymer surfaces. Trans Am Soc Artif Intern Organs 20 B (1974) 449-455
17. Lee E.S., and Kim S.W. Adsorbed glycoproteins in platelet adhesion onto polymer surfaces: significance of terminal galactose units. Trans Am Soc Artif Intern Organs 25 (1979) 124-132
18. Park K., Mosher D.F., and Cooper S.L. Acute surface-induced thrombosis in the canine exvivo model-importance of protein-composition of the initial monolayer and platelet activation. J Biomed Mater Res 20 (1986) 589-612
19. Ishikawa Y., Sasakawa S., Takase M., and Osada Y. Effect of albumin immobilization by plasma polymerization on platelet reactivity. Thromb Res 35 (1984) 193-202
20. Kang I.K., Kwon B.K., Lee J.H., and Lee H.B. Immobilization of proteins on poly(methyl methacrylate) films. Biomaterials 14 (1993) 787-792
21. Kamath K.R., Demeo D., and Park K. Albumin grafting on polymer surfaces by gamma-irradiation. Abstr Pap Am Chem Soc 206 (1993) 202 -POLY
22. Munro M.S., Quattrone A.J., Ellsworth S.R., Kulkarni P., and Eberhart R.C. Alkyl substituted polymers with enhanced albumin affinity. Trans Am Soc Artif Intern Organs 27 (1981) 499-503
23. Eberhart R.C., Munro M.S., Frautschi J.R., Lubin M., Clubb F.J., Miller C.W., et al. Influence of endogenous albumin binding on blood-material interactions. Ann NY Acad Sci 516 (1987) 78-95
24. Eberhart R.C. Surface treatments to improve the albumin affinity and blood compatibility of polymers. IEEE Eng Med Biol Mag 8 (1989) 26-29
25. Eberhart R.C., Huo H.H., and Nelson K. Cardiovascular materials. MRS Bull 16 (1991) 50-54
26. Frautschi J.R., Eberhart R.C., and Hubbell J.A. Alkylated cellulosic membranes with enhanced albumin affinity: influence of competing proteins. J Biomater Sci-Polym Ed 7 (1995) 563-575
27. Nelson K.D., Eisenbaumer R., Pomerantz M., and Eberhart R.C. High affinity polyethylene oxide for improved biocompatibility. ASAIO J 42 (1996) M884-M889
28. Guidoin R.G., Awad J., Brassard A., Domurado D., Lawny F., Barbotin J.N., et al. Blood compatibility of silicone rubber chemically coated with cross-linked albumin. Biomaterials, medical devices, and artificial organs 4 (1976) 205-224
29. Guidoin R.G., King M.W., Awad J., Martin L., Domurado D., Marois M., et al. Albumin coated and critical point dried polyester prostheses as substitutes in the thoracic aorta of dogs. Trans Am Soc Artif Intern Organs 29 (1983) 290-295
30. Kottkemarchant K., Anderson J.M., Umemura Y., and Marchant R.E. Effect of albumin coating on the invitro blood compatibility of Dacron arterial prostheses. Biomaterials 10 (1989) 147-155
31. Marois Y., Chakfe N., Guidoin R., Duhamel R.C., Roy R., Marois M., et al. An albumin-coated polyester arterial graft: in vivo assessment of biocompatibility and healing characteristics. Biomaterials 17 (1996) 3-14
32. al-Khaffaf H., and Charlesworth D. Albumin-coated vascular prostheses: a five-year follow-up. J Vasc Surg 23 (1996) 686-690
33. Kudo F.A., Nishibe T., Miyazaki K., Flores J., and Yasuda K. Albumin-coated knitted Dacron aortic prostheses. Study of postoperative inflammatory reactions. Int Angiol 21 (2002) 214-217
34. Gott V.L., Koepke D.E., Daggett R.L., Zarnstorff W., and Young W.P. The coating of intravascular plastic prostheses with colloidal graphite. Surgery 50 (1961) 382-389
35. Gott V.L., Whiffen J.D., and Dutton R.C. Heparin bonding on colloidal graphite surfaces. Science 142 (1963) 1297-1298
36. Olcott E.L. Pyrolytic biocarbon materials. J Biomed Mater Res 8 (1974) 209-217
37. Goldfarb D., Houk J.A., Moore J.L., and Gain D.L. Graphite-expanded polytetrafluoroethylene: improved small artery prosthesis. Trans Am Soc Artif Intern Organs 23 (1977) 268-276
38. Debski R., Borovetz H., Haubold A., and Hardesty R. Polytetrafluoroethylene grafts coated with Ulti carbon. Trans Am Soc Artif Intern Organs 28 (1982) 456-458
39. Scott S.M., Gaddy L.R., and Parra S. Pyrolytic carbon-coated vascular prostheses. J Surg Res 29 (1980) 395-405
40. Tsuchida H., Cameron B.L., Marcus C.S., and Wilson S.E. Modified polytetrafluoroethylene: indium-111 labeled platelet deposition on carbon-lined and high-porosity polytetrafluoroethylene grafts. J Vasc Surg 16 (1992) 643-650
41. Arabi H., Mirzadeh H., Ahmadi S.H., Amanpour S., Rabbani S., and Abdi A. In vitro and in vivo hemocompatibility evaluation of graphite coated polyester vascular grafts. Int J Artif Organs 27 (2004) 691-698
42. Kapfer X., Meichelboeck W., and Groegler F.M. Comparison of carbon-impregnated and standard ePTFE prostheses in extra-anatomical anterior tibial artery bypass: a prospective randomized multicenter study. Eur J Vasc Endovasc Surg 32 (2006) 155-168
43. Prunotto M., Isaia C., Gatti M.A., Monari E., Pasquino E., and Galloni M. Nitinol Carbofilm coated stents for peripheral applications: study in the porcine model. J Mater Sci-Mater Med 16 (2005) 1231-1238
44. Bartorelli A.L., Trabattoni D., Montorsi P., Fabbiocchi F., Galli S., Ravagnani P., et al. Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent (TM): the ANTARES study. Catheter Cardiovasc Interv 55 (2002) 150-156
45. Sick P.B., Gelbrich G., Kalnins U., Erglis A., Bonan R., Aengevaeren W., et al. Comparison of early and late results of a carbofilm-coated stent versus a pure high-grade stainless steel stent (the carbostent-trial). Am J Cardiol 93 (2004) 1351-1356
46. Sick P.B., Brosteanu O., Ulrich M., Thiele H., Niebauer J., Busch I., et al. Prospective randomized comparison of early and late results of a carbonized stent versus a high-grade stainless steel stent of identical design: the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial. Am Heart J 149 (2005) 681-688
47. Kim Y.H., Lee C.W., Hong M.K., Park S.W., Tahk S.J., Yang J.Y., et al. Randomized comparison of carbon ion-implanted stent versus bare metal stent in coronary artery disease: the Asian Pacific Multicenter Arthos Stent Study (PASS) trial. Am Heart J 149 (2005) 336-341
48. Tegoulia V.A., Rao W.S., Kalambur A.T., Rabolt J.R., and Cooper S.L. Surface properties, fibrinogen adsorption, and cellular interactions of a novel phosphorylcholine-containing self-assembled monolayer on gold. Langmuir 17 (2001) 4396-4404
49. Lu J.R., Murphy E.F., Su T.J., Lewis A.L., Stratford P.W., and Satija S.K. Reduced protein adsorption on the surface of a chemically grafted phospholipid monolayer. Langmuir 17 (2001) 3382-3389
50. Glasmastar K., Larsson C., Hook F., and Kasemo B. Protein adsorption on supported phospholipid bilayers. J Colloid Interface Sci 246 (2002) 40-47
51. Andersson A.S., Glasmastar K., Sutherland D., Lidberg U., and Kasemo B. Cell adhesion on supported lipid bilayers. J Biomed Mater Res Part A 64A (2003) 622-629
52. Vermette P., Gauvreau V., Pezolet M., and Laroche G. Albumin and fibrinogen adsorption onto phosphatidylcholine monolayers investigated by Fourier transform infrared spectroscopy. Colloid Surf B-Biointerfaces 29 (2003) 285-295
53. Winger T.M., Ludovice P.J., and Chaikof E.L. Formation and stability of complex membrane-mimetic monolayers on solid supports. Langmuir 15 (1999) 3866-3874
54. Kaladhar K., and Sharma C.P. Cell mimetic lateral stabilization of outer cell mimetic bilayer on polymer surfaces by peptide bonding and their blood compatibility. J Biomed Mater Res Part A 79A (2006) 23-35
55. Kaladhar K., and Sharma C.P. Supported cell mimetic monolayers and their interaction with blood. Langmuir 20 (2004) 11115-11122
56. Stine R., Pishko M.V., Hampton J.R., Dameron A.A., and Weiss P.S. Heat-stabilized phospholipid films: film characterization and the production of protein-resistant surfaces. Langmuir 21 (2005) 11352-11356
57. Marra K.G., Winger T.M., Hanson S.R., and Chaikof E.L. Cytomimetic biomaterials. 1. In-situ polymerization of phospholipids on an alkylated surface. Macromolecules 30 (1997) 6483-6488
58. Marra K.G., Kidani D.D.A., and Chaikof E.L. Cytomimetic biomaterials. 2. In-situ polymerization of phospholipids on a polymer surface. Langmuir 13 (1997) 5697-5701
59. Orban J.M., Faucher K.M., Dluhy R.A., and Chaikof E.L. Cytomimetic biomaterials. 4. In-situ photopolymerization of phospholipids on an alkylated surface. Macromolecules 33 (2000) 4205-4212
60. Ross E.E., Rozanski L.J., Spratt T., Liu S.C., O'Brien D.F., and Saavedra S.S. Planar supported lipid bilayer polymers formed by vesicle fusion. 1. Influence of diene monomer structure and polymerization method on film properties. Langmuir 19 (2003) 1752-1765
61. Ross E.E., Spratt T., Liu S.C., Rozanski L.J., O'Brien D.F., and Saavedra S.S. Planar supported lipid bilayer polymers formed by vesicle fusion. 2. Adsorption of bovine serum albumin. Langmuir 19 (2003) 1766-1774
62. Kim H.K., Kim K., and Byun Y. Preparation of a chemically anchored phospholipid monolayer on an acrylated polymer substrate. Biomaterials 26 (2005) 3435-3444
63. Jordan S.W., Faucher K.M., Caves J.M., Apkarian R.P., Rele S.S., Sun X.L., et al. Fabrication of a phospholipid membrane-mimetic film on the luminal surface of an ePTFE vascular graft. Biomaterials 27 (2006) 3473-3481
64. Chandy T., Das G.S., Wilson R.F., and Rao G.H.R. Use of plasma glow for surface-engineering biomolecules to enhance bloodcompatibility of Dacron and PTFE vascular prosthesis. Biomaterials 21 (2000) 699-712
65. Huang X.J., Xu Z.K., Wan L.S., Wang Z.G., and Wang J.L. Surface modification of polyacrylonitrile-based membranes by chemical reactions to generate phospholipid moieties. Langmuir 21 (2005) 2941-2947
66. Feng W., Zhu S.P., Ishihara K., and Brash J.L. Adsorption of fibrinogen and lysozyme on silicon grafted with poly(2-methacryloyloxyethyl phosphorylcholine) via surface-initiated atom transfer radical polymerization. Langmuir 21 (2005) 5980-5987
67. Chung Y.C., Chiu Y.H., Wu Y.W., and Tao Y.T. Self-assembled biomimetic monolayers using phospholipid-containing disulfides. Biomaterials 26 (2005) 2313-2324
68. Iwasaki Y., and Ishihara K. Phosphorylcholine-containing polymers for biomedical applications. Anal Bioanal Chem 381 (2005) 534-546
69. Lewis A.L., and Stratford P.W. Phosphorylcholine-coated stents. J Long Term Eff Med Implants 12 (2002) 231-250
70. Yoneyama T., Ishihara K., Nakabayashi N., Ito M., and Mishima Y. Short-term in vivo evaluation of small-diameter vascular prosthesis composed of segmented poly(etherurethane) 2-methacryloyloxyethyl phosphorylcholine polymer blend. J Biomed Mater Res 43 (1998) 15-20
71. Yoneyama T., Sugihara K., Ishihara K., Iwasaki Y., and Nakabayashi N. The vascular prosthesis without pseudointima prepared by anti thrombogenic phospholipid polymer. Biomaterials 23 (2002) 1455-1459
72. Ishihara K., and Iwasaki Y. Biocompatible elastomers composed of segmented polyurethane and 2-methacryloyloxyethyl phosphorylcholine polymer. Polym Adv Technol 11 (2000) 626-634
73. Chen C.Y., Ofenloch J.C., Yianni Y.P., Hanson S.R., and Lumsden A.B. Phosphorylcholine coating of ePTFE reduces platelet deposition and neointimal hyperplasia in arteriovenous grafts. J Surg Res 77 (1998) 119-125
74. Chen C.Y., Lumsden A.B., Ofenloch J.C., Noe B., Campbell E.J., Stratford P.W., et al. Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model. Ann Vasc Surg 11 (1997) 74-79
75. Whelan D.M., van der Giessen W.J., Krabbendam S.C., van Vliet E.A., Verdouw P.D., Serruys P.W., et al. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 83 (2000) 338-345
76. Lewis A.L., Tolhurst L.A., and Stratford P.W. Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation. Biomaterials 23 (2002) 1697-1706
77. Kuiper K.K.J., Robinson K.A., Chronos N.A.F., Cui J.H., Palmer S.J., and Nordrehaug J.E. Phosphorylcholine-coated metallic stents in rabbit iliac and porcine coronary arteries. Scand Cardiovasc J 32 (1998) 261-268
78. Galli M., Bartorelli A., Bedogni F., DeCesare N., Klugmann S., Maiello T., et al. Italian BiodivYsio open registry (BiodivYsio PC-coated stent): study of clinical outcomes of the implant of a PC-coated coronary stent. J Invasive Cardiol 12 (2000) 452-458
79. Baumgartner H.R., Muggli R., Tschopp T.B., and Turitto V.T. Platelet-adhesion, release and aggregation in flowing blood: effects of surface properties and platelet-function. Thromb Haemost 35 (1976) 124-138
80. Barnes M.J., and Macintyre D.E. Platelet-reactivity of isolated constituents of the blood-vessel wall. Haemostasis 8 (1979) 158-170
81. Ito S., Ishimaru S., and Wilson S.E. Application of coacervated alpha-elastin to arterial prostheses for inhibition of anastomotic intimal hyperplasia. ASAIO J 44 (1998) M501-M505
82. McPherson D.T., Morrow C., Minehan D.S., Wu J., Hunter E., and Urry D.W. Production and purification of a recombinant elastomeric polypeptide, G-(VPGVG)19-VPGV, from Escherichia coli. Biotechnology progress 8 (1992) 347-352
83. Daniell H., Guda C., McPherson D.T., Zhang X., Xu J., and Urry D.W. Hyperexpression of a synthetic protein-based polymer gene. Methods Mol Biol 63 (1997) 359-371
84. Trabbic-Carlson K., Setton L.A., and Chilkoti A. Swelling and mechanical behaviors of chemically cross-linked hydrogels of elastin-like polypeptides. Biomacromolecules 4 (2003) 572-580
85. Nagapudi K., Brinkman W.T., Leisen J., Thomas B.S., Wright E.R., Haller C., et al. Protein-based thermoplastic elastomers. Macromolecules 38 (2005) 345-354
86. Defife K.M., Hagen K.M., Clapper D.L., and Anderson J.M. Photochemically immobilized polymer coatings: effects on protein adsorption, cell adhesion, and leukocyte activation. J Biomater Sci-Polym Ed 10 (1999) 1063-1074
87. Woodhouse K.A., Klement P., Chen V., Gorbet M.B., Keeley F.W., Stahl R., et al. Investigation of recombinant human elastin polypeptides as non-thrombogenic coatings. Biomaterials 25 (2004) 4543-4553
88. Jordan S.W., Haller C.A., Sallach R.E., Apkarian R.P., Hanson S.R., and Chaikof E.L. The effect of a recombinant elastin-mimetic coating of an ePTFE prosthesis on acute thrombogenicity in a baboon arteriovenous shunt. Biomaterials 28 (2007) 1191-1197
89. Clagett G.P., Burkel W.E., Sharefkin J.B., Ford J.W., Hufnagel H., Vinter D.W., et al. Platelet reactivity in vivo in dogs with arterial prostheses seeded with endothelial cells. Circulation 69 (1984) 632-639
90. Hess F., Steeghs S., Jerusalem R., Reijnders O., Jerusalem C., Braun B., et al. Patency and morphology of fibrous polyurethane vascular prostheses implanted in the femoral-artery of dogs after seeding with subcultivated endothelial cells. Eur J Vasc Surg 7 (1993) 402-408
91. Pasic M., MullerGlauser W., vonSegesser L., Odermatt B., Lachat M., and Turina M. Endothelial cell seeding improves patency of synthetic vascular grafts: manual versus automatized method. Eur J Cardiothorac Surg 10 (1996) 372-379
92. Sugitachi A., and Takagi K. Antithrombogenicity of immobilized urokinase: clinical application. Int J Artif Organs 1 (1978) 88-92
93. Aoshima R., Kanda Y., Takada A., and Yamashita A. Sulfonated poly(vinylidene fluoride) as a biomaterial: immobilization of urokinase and biocompatibility. J Biomed Mater Res 16 (1982) 289-299
94. Kitamoto Y., Tomita M., Kiyama S., Inoue T., Yabushita Y., Sato T., et al. Antithrombotic mechanisms of urokinase immobilized polyurethane. Thromb Haemost 65 (1991) 73-76
95. Lai Z.F., Imamura T., Koike N., and Kitamoto Y. Urokinase-immobilization suppresses inflammatory responses to polyurethane tubes implanted in rabbit muscles. J Biomed Mater Res 76 (2006) 81-85
96. vonSegesser L.K. Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support. Ann Thorac Surg 61 (1996) 330-335
97. Hsu L.C. Heparin-coated cardiopulmonary bypass circuits: current status. Perfusion 16 (2001) 417-428
98. Hubbell J.A. Pharmacological modification of materials. Cardiovasc Pathol 2 (1993) S121-S127
99. Olsson P., Sanchez J., Mollnes T.E., and Riesenfeld J. On the blood compatibility of end-point immobilized heparin. J Biomater Sci-Polym Ed 11 (2000) 1261-1273
100. Tanzi M.C. Bioactive technologies for hemocompatibility. Expert Rev Med Devices 2 (2005) 473-492
101. Sperling C., Schweiss R.B., Streller U., and Werner C. In vitro hemocompatibility of self-assembled monolayers displaying various functional groups. Biomaterials 26 (2005) 6547-6557
102. Huang L.Y., and Yang M.C. Hemocompatibility of layer-by-layer hyaluronic acid/heparin nanostructure coating on stainless steel for cardiovascular stents and its use for drug delivery. J Nanosci Nanotech 6 (2006) 3163-3170
103. Laredo J., Xue L., Husak V.A., Ellinger J., and Greisler H.P. Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. Am J Surg 186 (2003) 556-560
104. Laredo J., Xue L., Husak V.A., Ellinger J., Singh G., Zamora P.O., et al. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. J Vasc Surg 39 (2004) 1059-1065
105. Li Y.L., Neoh K.G., and Kang E.T. Plasma protein adsorption and thrombus formation on surface functionalized polypyrrole with and without electrical stimulation. J Colloid Interface Sci 275 (2004) 488-495
106. Chen H., Chen Y., Sheardown H., and Brook M.A. Immobilization of heparin on a silicone surface through a heterobifunctional PEG spacer. Biomaterials 26 (2005) 7418-7424
107. Wang A.F., Cao T., Tang H.Y., Liang X.M., Black C., Salley S.O., et al. Immobilization of polysaccharides on a fluorinated silicon surface. Colloid Surf B-Biointerfaces 47 (2006) 57-63
108. Keuren J.F.W., Wielders S.J.H., Driessen A., Verhoeven M., Hendriks M., and Lindhout T. Covalently-bound heparin makes collagen thromboresistant. Arterioscler Thromb Vasc Biol 24 (2004) 613-617
109. Luong-Van E., Grondahl L., Chua K.N., Leong K.W., Nurcombe V., and Cool S.M. Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials 27 (2006) 2042-2050
110. Larm O., Larsson R., and Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater Med Devices Artif Organs 11 (1983) 161-173
111. Pasche B., Elgue G., Olsson P., Riesenfeld J., and Rasmuson A. Binding of antithrombin to immobilized heparin under varying flow conditions. Artif Organs 15 (1991) 481-491
112. Elgue G., Blomback M., Olsson P., and Riesenfeld J. On the mechanism of coagulation inhibition on surfaces with end-point immobilized heparin. Thromb Haemost 70 (1993) 289-293
113. Devine C., and McCollum C. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg 40 (2004) 924-931
114. Begovac P.C., Thomson R.C., Fisher J.L., Hughson A., and Gallhagen A. Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization. Eur J Vasc Endovasc Surg 25 (2003) 432-437
115. Lin P.H., Chen C., Bush R.L., Yao Q., Lumsden A.B., and Hanson S.R. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model. J Vasc Surg 39 (2004) 1322-1328
116. Heyligers J.M.M., Verhagen H.J.M., Rotmans J.I., Weeterings C., de Groot P.G., Moll F.L., et al. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts. J Vasc Surg 43 (2006) 587-591
117. Walluscheck K.P., Bierkandt S., Brandt M., and Cremer J. Infrainguinal ePTFE vascular graft with bioactive surface heparin bonding: first clinical results. J Cardiovasc Surg 46 (2005) 425-430
118. Bosiers M., Deloose K., Verbist J., Schroe H., Lauwers G., Lansink W., et al. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results. J Vasc Surg 43 (2006) 313-318
119. Peeters P., Verbist J., Deloose K., and Bosiers M. Results with heparin bonded polytetrafluoroethylene grafts for femorodistal bypasses. J Cardiovasc Surg 47 (2006) 407-413
120. Hardhammar P.A., vanBeusekom H.M.M., Emanuelsson H.U., Hofma S.H., Albertsson P.A., Verdouw P.D., et al. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 93 (1996) 423-430
121. Vrolix M.C.M., Legrand V.M., Reiber J.H.C., Grollier G., Schalij M.J., Brunel P., et al. Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). Am J Cardiol 86 (2000) 385-389
122. Wohrle J., Al-Khayer E., Grotzinger U., Schindler C., Kochs M., Hombach V., et al. Comparison of the heparin coated vs the uncoated Jostent (R): no influence on restenosis or clinical outcome. Eur Heart J 22 (2001) 1808-1816
123. Edmunds L.H., and Colman R.W. Thrombin during cardiopulmonary bypass. Ann Thorac Surg 82 (2006) 2315-2322
124. Seifert B., Romaniuk P., and Groth T. Covalent immobilization of hirudin improves the haemocompatibility of polylactide-polyglycolide in vitro. Biomaterials 18 (1997) 1495-1502
125. Phaneuf M.D., Berceli S.A., Bide M.J., Quist W.C., and LoGerfo F.W. Covalent linkage of recombinant hirudin to poly(ethylene terephthalate) (Dacron): creation of a novel antithrombin surface. Biomaterials 18 (1997) 755-765
126. Berceli S.A., Phaneuf M.D., and LoGerfo P.W. Evaluation of a novel hirudin-coated polyester graft to physiologic flow conditions: hirudin bioavailability and thrombin uptake. J Vasc Surg 27 (1998) 1117-1127
127. Phaneuf M.D., Dempsey D.J., Bide M.J., Szycher M., Quist W.C., and LoGerfo F.W. Bioengineering of a novel small diameter polyurethane vascular graft with covalently bound recombinant hirudin. ASAIO J 44 (1998) M653-M658
128. Phaneuf M.D., Szycher M., Berceli S.A., Dempsey D.J., Quist W.C., and LoGerfo F.W. Covalent linkage of recombinant hirudin to a novel ionic poly(carbonate) urethane polymer with protein binding sites: determination of surface antithrombin activity. Artif Organs 22 (1998) 657-665
129. Wyers M.C., Phaneuf M.D., Rzucidlo E.M., Contreras M.A., LoGerfo F.W., and Quist W.C. In vivo assessment of a novel Dacron surface with covalently bound recombinant hirudin. Cardiovasc Pathol 8 (1999) 153-159
130. Lahann J., Klee D., Pluester W., and Hoecker H. Bioactive immobilization of r-hirudin on CVD-coated metallic implant devices. Biomaterials 22 (2001) 817-826
131. Kishida A., Ueno Y., Maruyama I., and Akashi M. Immobilization of human thrombomodulin on biomaterials: evaluation of the activity of immobilized human thrombomodulin. Biomaterials 15 (1994) 1170-1174
132. Kishida A., Ueno Y., Fukudome N., Yashima E., Maruyama I., and Akashi M. Immobilization of human thrombomodulin onto poly(ether urethane urea) for developing antithrombogenic blood-contacting materials. Biomaterials 15 (1994) 848-852
133. Kishida A., Akatsuka Y., Yanagi M., Aikou T., Maruyama I., and Akashi M. In vivo and ex vivo evaluation of the antithrombogenicity of human thrombomodulin immobilized biomaterials. ASAIO J 41 (1995) M369-M374
134. 2 plasma-initiated vapour phase graft polymerization of acrylic acid onto polytetrafluoroethylene for immobilization of human thrombomodulin. Biomaterials 18 (1997) 1139-1145
135. Li J.M., Singh M.J., Nelson P.R., Hendricks G.M., Itani M., Rohrer M.J., et al. Immobilization of human thrombomodulin to expanded polytetrafluoroethylene. J Surg Res 105 (2002) 200-208
136. Sperling C., Konig U., Hermel G., Werner C., Muller M., Simon F., et al. Immobilization of human thrombomodulin onto PTFE. J Mater Sci Mater Med 8 (1997) 789-791
137. Sperling C., Salchert K., Streller U., and Werner C. Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro. Biomaterials 25 (2004) 5101-5113
138. Han H.S., Yang S.L., Yeh H.Y., Lin J.C., Wu H.L., and Shi G.Y. Studies of a novel human thrombomodulin immobilized substrate: surface characterization and anticoagulation activity evaluation. J Biomater Sci-Polym Ed 12 (2001) 1075-1089
139. Cazalis C.S., Haller C.A., Sease-Cargo L., and Chaikof E.L. C-terminal site-specific PEGylation of a truncated thrombomodulin mutant with retention of full bioactivity. Bioconjugate Chem 15 (2004) 1005-1009
140. Sun X.L., Stabler C.L., Cazalis C.S., and Chaikof E.L. Carbohydrate and protein immobilization onto solid surfaces by sequential Diels-Alder and azide-alkyne cycloadditions. Bioconjugate Chem 17 (2006) 52-57
141. Tseng P.Y., Jordan S.W., Sun X.L., and Chaikof E.L. Catalytic efficiency of a thrombomodulin-functionalized membrane-mimetic film in a flow model. Biomaterials 27 (2006) 2768-2775
142. Feng J., Tseng P.Y., Faucher K.M., Orban J.M., Sun X.L., and Chaikof E.L. Functional reconstitution of thrombomodulin within a substrate-supported membrane-mimetic polymer film. Langmuir 18 (2002) 9907-9913
143. Tseng P.Y., Rele S.S., Sun X.L., and Chaikof E.L. Membrane-mimetic films containing thrombomodulin and heparin inhibit tissue factor-induced thrombin generation in a flow model. Biomaterials 27 (2006) 2637-2650
144. Schomig A., Neumann F.J., Kastrati A., Schuhlen H., Blasini R., Hadamitzky M., et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334 (1996) 1084-1089
145. Mishkel G.J., Aguirre F.V., Ligon R.W., Rocha-Singh K.J., and Lucore C.L. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. J Am Coll Cardiol 34 (1999) 1884-1890
146. Kolansky D.M., Klugherz B.D., Curran S.C., Herrmann H.C., Magness K., Wilensky R.L., et al. Combination therapy with clopidogrel and aspirin after coronary stenting. Catheter Cardiovasc Interv 50 (2000) 276-279
147. Muller C., Buttner H.J., Petersen J., and Roskamm H. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 101 (2000) 590-593
148. Mehta S.R., Yusuf S., Peters R.J.G., Bertrand M.E., Lewis B.S., Natarajan M.K., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 (2001) 527-533
149. Tangelder M.J.D., Algra A., Lawson J.A., Eikelboom B.C., Tangelder M.J.D., Algra A., et al. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial. Lancet 355 (2000) 346-351
150. Quinn M.J., and Fitzgerald D.J. Ticlopidine and clopidogrel. Circulation 100 (1999) 1667-1672
151. Black C., and Paterson K.R. New antiplatelet agents: ticlopidine and clopidogrel. Antiplatelet therapy but at what cost?. Adverse Drug React Toxicol Rev 20 (2001) 277-303
152. McCarthy M.W., and Kockler D.R. Clopidogrel-associated leukopenia. Ann Pharmacother 37 (2003) 216-219
153. Chemnitz J., Sohngen D., Schulz A., Diehl V., and Scheid C. Fatal toxic bone marrow failure associated with Clopidogrel. Eur J Haematol 71 (2003) 473-474
154. Kidane A.G., Salacinski H., Tiwari A., Bruckdorfer K.R., and Seifalian A.M. Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces. Biomacromolecules 5 (2004) 798-813
155. Groves P.H., Banning A.P., Penny W.J., Newby A.C., Cheadle H.A., and Lewis M.J. The effects of exogenous nitric-oxide on smooth-muscle cell-proliferation following porcine carotid angioplasty. Cardiovasc Res 30 (1995) 87-96
156. Joseph G., and Sharma C.P. Prostacyclin immobilized albuminated surfaces. J Biomed Mater Res 21 (1987) 937-945
157. Chandy T., and Sharma C.P. The antithrombotic effect of prostaglandin-E1 immobilized on albuminated polymer matrix. J Biomed Mater Res 18 (1984) 1115-1124
158. Chandy T., Das G.S., Wilson R.F., and Rao G.H.R. Surface-immobilized biomolecules on albumin modified porcine pericardium for preventing thrombosis and calcification. Int J Artif Organs 22 (1999) 547-558
159. Aldenhoff Y.B.J., Pijpers A.P., and Koole L.H. Synthesis of a new photoreactive derivative of dipyridamole and its use in the manufacture of artificial surfaces with low thrombogenicity. Bioconjugate Chem 8 (1997) 296-303
160. Aldenhoff Y.B.J., van der Veen F.H., ter Woorst J., Habets J., Poole-Warren L.A., and Koole L.H. Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin (R)) coating on its lumenal surface. J Biomed Mater Res 54 (2001) 224-233
161. Aldenhoff Y.B.J., and Koole L.H. Platelet adhesion studies on dipyridamole coated polyurethane surfaces. Eur Cells Mater 5 (2003) 61-67
162. Paul W., and Sharma C.P. Acetylsalicylic acid loaded poly(vinyl alcohol) hemodialysis membranes: effect of drug release on blood compatibility and permeability. J Biomater Sci-Polym Ed 8 (1997) 755-764
163. Vasudev S.C., Chandy T., and Sharma C.P. Development of chitosan/polyethylene vinyl acetate co-matrix: controlled release of aspirin-heparin for preventing cardiovascular thrombosis. Biomaterials 18 (1997) 375-381
164. Rodriguez G., Gallardo A., San Roman J., Rebuelta M., Bermejo P., Bujan J., et al. New resorbable polymeric systems with antithrombogenic activity. J Mater Sci-Mater Med 10 (1999) 873-878
165. Rodriguez G., Gallardo A., Fernandez M., Rebuelta M., Bujan J., Bellon J., et al. Hydrophilic polymer drug from a derivative of salicylic acid: synthesis, controlled release studies and biological behavior. Macromol Biosci 4 (2004) 579-586
166. SanRoman J., Bujan J., Bellon J.M., Gallardo A., Escudero M.C., Jorge E., et al. Experimental study of the antithrombogenic behavior of Dacron vascular grafts coated with hydrophilic acrylic copolymers bearing salicylic acid residues. J Biomed Mater Res 32 (1996) 19-27
167. Fontaine A.B., Borsa J.J., Dos Passos S., Hoffer E.K., Bloch R.D., Starr F., et al. Evaluation of local abciximab delivery from the surface of a polymer-coated covered stent: in vivo canine studies. J Vasc Interv Radiol 12 (2001) 487-492
168. Viscardi P.J., Page E.A., Clark H.G., Serafin D., and Klitzman B. Iloprost in alginate decreases the thrombogenicity of expanded polytetrafluoroethylene. J Reconstr Microsurg 13 (1997) 303-306
169. Herrmann R., Schmidmaier G., Markl B., Resch A., Hahnel I., Stemberger A., et al. Antithrombogenic coating of stents using a biodegradable drug delivery technology. Thromb Haemost 82 (1999) 51-57
170. Alt E., Haehnel I., Beilharz C., Prietzel K., Preter D., Stemberger A., et al. Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost. Circulation 101 (2000) 1453-1458
171. Voisard R., Stemberger A., Baur R., Herter T., Hahnel I., Resch A., et al. Triple-coated stents (hirudin/iloprost/paclitaxel): an in vitro approach for characterizing the antiproliferative potential of each individual compound. Int J Cardiol 102 (2005) 425-433
172. Smith D.J., Chakravarthy D., Pulfer S., Simmons M.L., Hrabie J.A., Citro M.L., et al. Nitric oxide-releasing polymers containing the [N(O)NO](-) group. J Med Chem 39 (1996) 1148-1156
173. Pulfer S.K., Ott D., and Smith D.J. Incorporation of nitric oxide-releasing crosslinked polyethyleneimine microspheres into vascular grafts. J Biomed Mater Res 37 (1997) 182-189
174. Saavedra J.E., Booth M.N., Hrabie J.A., Davies K.M., and Keefer L.K. Piperazine as a linker for incorporating the nitric oxide-releasing diazeniumdiolate group into other biomedically relevant functional molecules. J Org Chem 64 (1999) 5124-5131
175. Saavedra J.E., Mooradian D.L., Mowery K.A., Schoenfisch M.H., Citro M.L., Davies K.M., et al. Conversion of a polysaccharide to nitric oxide-releasing form. Dual-mechanism anticoagulant activity of diazeniumdiolated heparin. Bioorg Med Chem Lett 10 (2000) 751-753
176. Bohl K.S., and West J.L. Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation. Biomaterials 21 (2000) 2273-2278
177. Jun H.W., Taite L.J., and West J.L. Nitric oxide-producing polyurethanes. Biomacromolecules 6 (2005) 838-844
178. Mowery K.A., Schoenfisch M.H., Saavedra J.E., Keefer L.K., and Meyerhoff M.E. Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials 21 (2000) 9-21
179. Annich G.M., Meinhardt J.P., Mowery K.A., Ashton B.A., Merz S.I., Hirschl R.B., et al. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers. Crit Care Med 28 (2000) 915-920
180. Schoenfisch M.H., Mowery K.A., Rader M.V., Baliga N., Wahr J.A., and Meyerhoff M.E. Improving the thromboresistivity of chemical sensors via nitric oxide release: fabrication and in vivo evaluation of NO-releasing oxygen-sensing catheters. Anal Chem 72 (2000) 1119-1126
181. Zhang H.P., Annich G.M., Miskulin J., Osterholzer K., Merz S.I., Bartlett R.H., et al. Nitric oxide releasing silicone rubbers with improved blood compatibility: preparation, characterization, and in vivo evaluation. Biomaterials 23 (2002) 1485-1494
182. Zhang H.P., Annich G.M., Miskulin J., Stankiewicz K., Osterholzer K., Merz S.I., et al. Nitric oxide-releasing fumed silica particles: synthesis, characterization, and biomedical application. J Am Chem Soc 125 (2003) 5015-5024
183. Batchelor M.M., Reoma S.L., Fleser P.S., Nuthakki V.K., Callahan R.E., Shanley C.J., et al. More lipophilic dialkyldiamine-based diazeniumdiolates: synthesis, characterization, and application in preparing thromboresistant nitric oxide release polymeric coatings. J Med Chem 46 (2003) 5153-5161
184. Frost M.C., Batchelor M.M., Lee Y.M., Zhang H.P., Kang Y.J., Oh B.K., et al. Preparation and characterization of implantable sensors with nitric oxide release coatings. Microchem J 74 (2003) 277-288
185. Fleser P.S., Nuthakki V.K., Malinzak L.E., Callahan R.E., Seymour M.L., Reynolds M.M., et al. Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of artcriovenous bridge grafts. J Vasc Surg 40 (2004) 803-811
186. Oh B.K., and Meyerhoff M.E. Spontaneous catalytic generation of nitric oxide from S-nitrosothiols at the surface of polymer films doped with lipophilic copper(II) complex. J Am Chem Soc 125 (2003) 9552-9553
187. Oh B.K., and Meyerhoff M.E. Catalytic generation of nitric oxide from nitrite at the interface of polymeric films doped with lipophilic Cu(Il)-complex: a potential route to the preparation of thromboresistant coatings. Biomaterials 25 (2004) 283-293
188. Duan X.B., and Lewis R.S. Improved haemocompatibility of cysteine-modified polymers via endogenous nitric oxide. Biomaterials 23 (2002) 1197-1203